TalkFDA
The Leader in Quality Life Science Training
Live Webinar

Analytical Lifecycle Management Under ICH Q14 and Q2(R2): What Changes Operationally

Clarifies how analytical lifecycle expectations affect development rationale, validation strategy, method change decisions, transfer activities, and continued performance monitoring.

Faculty
Meredith Crabtree
Format
Live + Post-live Continued Access
Session Details
📅
Date
August 21, 2026
🕙
Time
11 AM Eastern Time (US/Canada) | 3 PM GMT
Duration
90 Minutes
Register Now

GROUP SAVINGS: Get your team to attend for just $390.

Individual registrations available too.

Course Overview & Structure

Post-validation method changes need clearer scientific rationale.

Analytical teams now face lifecycle questions when validated methods require changes, transfers, monitoring decisions, or renewed justification years after approval.

It connects development documentation, validation evidence, control strategy, transfer readiness, and change management into practical analytical lifecycle decisions under ICH expectations.

The discussion moves from method development rationale into validation strategy, then follows methods through transfer, post-validation change control, and continued performance review. Each section links documentation expectations to the laboratory and quality decisions that determine whether a method remains scientifically sound.

WHAT YOU'LL LEARN
  • Define sufficient development evidence for method rationale
  • Set method flexibility boundaries before change control
  • Align validation strategy with ICH Q14 and Q2(R2) lifecycle expectations
  • Build analytical control strategies that support method maintenance
  • Decide when method changes need validation or scientific justification
  • Manage transfer variables across laboratories and sites
  • Monitor ongoing performance and identify meaningful analytical drift
Who Should Attend

Designed for professionals responsible for analytical methods, laboratory quality, validation evidence, regulatory documentation, and lifecycle-based change decisions.

Analytical DevelopmentQuality ControlQuality AssuranceValidationRegulatory AffairsCMCTechnical ServicesLaboratory OperationsManufacturing
Meredith Crabtree
Faculty

Meredith Crabtree

Quality Consultant, MLKC Consulting

Meredith Crabtree brings over 30 years of regulated industry experience across pharmaceutical, laboratory, medical device, biologics, and related operations. Her work in quality consulting, regulatory assessments, inspections, recall support, and training gives her practical grounding in how analytical lifecycle expectations translate into documentation, quality decisions, and inspection-ready method management.

After You Register

Everything related to your course lives in one place.

01

You receive confirmation and the course appears in your TalkFDA dashboard.

02

Your course page becomes the hub for joining the session and accessing materials.

03

At the scheduled time, click Join Session to enter the live Webex session.

04

After the session, playback becomes available on the same course page.

05

Complete the course and your certificate is unlocked in your learning history.

FDB1616
For Teams Seeking Deeper Implementation Support

Customized training is also available through TalkFDA Elite Training Labs.

This topic can also be delivered as a customized session for organizations seeking structured, implementation-focused training aligned with their internal processes and quality systems.

TalkFDA Elite Training Labs

Analytical Lifecycle Management Under ICH Q14 and Q2(R2):

What Changes Operationally

📅 August 21, 2026 🕛 11 AM Eastern | 3 PM GMT